Metraipolis › archive › dc_e2e22014bd02

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice — Europe PMC PMID:41902651

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41902651
DOI: 10.1002/acn3.70378
License (as archived): solo-consultazione
Archived: 2026-11-03T17:53:24.292Z
SHA-256 of the archived text: bf75d170c3b4b0e57f55ad08e8023c5343715b03c4850d9879241642c3363d37
Stable URL of this page: https://metraipolis.com/documento/dc_e2e22014bd02

How to cite

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice — Europe PMC PMID:41902651 — Europe PMC (en), https://europepmc.org/article/MED/41902651 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2e22014bd02 (Metraipolis archive dc_e2e22014bd02, sha256 bf75d170c3b4b0e57f55ad08e8023c5343715b03c4850d9879241642c3363d37)

BibTeX

@misc{dce2e22014bd02,
  title = {GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice — Europe PMC PMID:41902651},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41902651},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2e22014bd02; sha256 bf75d170c3b4b0e57f55ad08e8023c5343715b03c4850d9879241642c3363d37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41902651. Agents can read the archived copy with the MCP tool read_document.